Sinovac Biotech (SVA) Soars: Stock Rises 17.1% - Tale of the Tape

Sinovac Biotech Ltd. (NASDAQ: SVA) was a big mover last session, as its shares rose over 17% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the healthcare company, as the stock is now trading above the volatile price range of $6.42 to $6.83 in the past one-month timeframe.

In the last 30-day frame, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Sinovac currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include Cambrex Corporation. (NYSE: CBM), Alkermes plc (NASDAQ: ALKS) and Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN). While Alexion and Alkermes sport a Zacks Rank #1 (Strong Buy), Cambrex carries a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

 
ALKERMES INC (NASDAQ: ALKS): Free Stock Analysis Report
 
ALEXION PHARMA (NASDAQ: ALXN): Free Stock Analysis Report
 
CAMBREX CORP (NYSE: CBM): Free Stock Analysis Report
 
SINOVAC BIOTECH (NASDAQ: SVA): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research